Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 13/2014

01-12-2014 | Breast Oncology

An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer

Authors: Nedret Kilic, PhD, Mine Yavuz Taslipinar, MD, Yildiz Guney, PhD, MD, Ercument Tekin, MD, Erhan Onuk, MD

Published in: Annals of Surgical Oncology | Issue 13/2014

Login to get access

Abstract

Background

Reactive oxygen species (free radicals) play an important role in carcinogenesis. Extensive antioxidant defense mechanisms counteract free radicals in mammalian cells. Oxidative stress is a disturbance in the balance between the production of free radicals and antioxidant defenses. There is direct evidence that oxidative stress and lipid peroxidation (LPO) are linked to the etiology of breast cancer. The increasing global incidence of breast cancer emphasizes the need to understand the various mechanisms involved in breast tumorigenesis. The present study was undertaken to investigate the oxidative stress and antioxidant status in the blood samples of patients with breast cancer.

Methods

The present study was based on 23 women who were surgically treated at Gazi University, Faculty of Medicine, Department of General Surgery. The malondialdehyde (MDA) levels as an index of LPO along with the examination of superoxide dismutase (SOD) activities and advanced oxidation protein product (AOPP) and thioredoxin (Trx) levels were determined in the blood samples of 23 patients with breast cancer and 13 healthy controls.

Results

MDA, AOPP, and Trx levels and SOD activities were significantly higher in patients with breast cancer than the controls.

Conclusions

The results showed that oxidative stress may be related to breast cancer and especially some molecules, such as Trx and AOPP, may be useful biomarkers in breast cancer diagnosis and treatment. More detailed knowledge related to the pathophysiology of these molecules could provide valuable information on the origin and development of malignant tumors, such as breast cancer.
Literature
1.
2.
Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011;711:167–73.PubMedCrossRef
3.
Prescott J, Wentzensen IM, Savage SA, De Vivo I. Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res. 2012;730:75–84.PubMedCentralPubMedCrossRef
4.
Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, et al. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol. 2011;80:347–68.PubMedCrossRef
5.
Huang TT, Zou Y, Corniola R. Oxidative stress and adult neurogenesis—effects of radiation and superoxide dismutase deficiency. Semin Cell Dev Biol. 2012;23:738–44.PubMedCentralPubMedCrossRef
6.
Powis G, Montfort WR. Properties and biological activities of thioredoxins. Ann Rev Pharmacol Toxicol. 2001;41:261–95.CrossRef
7.
Gasdaska PY, Oblong JE, Cotgreave IA, Powis G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim Biophys Acta. 1994;1218:292–6.PubMedCrossRef
8.
Luthman M, Holgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry. 1982;21:6628–33.PubMedCrossRef
9.
Powis G, Oblong JE, Gasdaska PY, Berggren M, Hill S, Kirkpatrick DL. The thioredoxin/thioredoxin reductase redox system and control of cell growth. Oncol Res. 1994;6:539–44.PubMed
10.
11.
Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med. 2001;31:1287–12.PubMedCrossRef
12.
Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol. 1979;135:372–6.PubMed
13.
Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.PubMed
14.
Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–13.PubMedCrossRef
15.
Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38:96–109.PubMedCrossRef
16.
Cooke MS, Evans MD, Dizdaroğlu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;10:1195–214.CrossRef
17.
Gupta RK, Patel AK, Kumari R, Chugh S, Shrivastav C, Mehra S, Sharma AN. Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a case control study. Asian Pac J Cancer Prev. 2012;13:6295–8.PubMedCrossRef
18.
Gonenc A, Ozkan Y, Torun M, Simsek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 2001;26:141–4.PubMedCrossRef
19.
Yeh CC, Hou MF, Tsai SM, et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta. 2005;361:104–11.PubMedCrossRef
20.
Rajneesh CP, Manimaran A, Sasikala KR, Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J. 2008;49:640–3.PubMed
21.
Polat FM, Taysi S, Gul M. Oxidant/antioxidant status in blood of patients with malignant breast tumor and benign breast disease. Cell Biochem Funct. 2002;20:327–31.PubMedCrossRef
22.
Ray G, Batras S, Shukla NK. Lipid peroxidation, free radical production and antioxidant status in tissues of breast cancer. Breast Cancer Res Treat. 2000;59:163–70.PubMedCrossRef
23.
Oytun P, Ozay O, Mine EI. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem. 2000;33:279–84.CrossRef
24.
Capeillere-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta. 2004;1689:91–102.PubMedCrossRef
25.
Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis. 2002;162:221–5.PubMedCrossRef
26.
Lazarova M, Stejskal D, Lacnak B, et al. The antioxidant acetylcysteine reduces oxidative stress by decreasing level of AOPPs. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004;148:131–3.PubMedCrossRef
27.
Kosova F, Çetin B, Akıncı M, et al. Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer. Endocrine Tumors. 2007;14:2616–20.
28.
29.
Ueno M, Matsutani Y, Nakamura H, et al. Possible association of thioredoxin and p53 in breast cancer. Immunol Lett. 2000;75:15–20.PubMedCrossRef
30.
Lincoln DT, Ali Amadi LM, Tonissen KF, Clarke FM. The thioredoxin–thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 2003;23:2425–33.PubMed
Metadata
Title
An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer
Authors
Nedret Kilic, PhD
Mine Yavuz Taslipinar, MD
Yildiz Guney, PhD, MD
Ercument Tekin, MD
Erhan Onuk, MD
Publication date
01-12-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 13/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3859-3

Other articles of this Issue 13/2014

Annals of Surgical Oncology 13/2014 Go to the issue

Healthcare Policy and Outcomes

Volume-Outcome in Cancer Surgery: Why has the Data Not Affected Policy Change?

Head and Neck Oncology

Assessment of Erlotinib as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer Patients

Melanomas

International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin

Thoracic Oncology

Homozygous GNAS 393C-Allele Carriers with Locally Advanced Esophageal Cancer Fail to Benefit from Platinum-Based Preoperative Chemoradiotherapy

Endocrine Tumors

Failure of Radioactive Iodine in the Treatment of Hyperthyroidism

Gynecologic Oncology

Cytoreductive Surgery Under Aminolevulinic Acid-Mediated Photodynamic Diagnosis Plus Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Ovarian Cancer and Primary Peritoneal Carcinoma: Results of a Phase I Trial